Eli Lilly (LLY)
(Delayed Data from NYSE)
$859.88 USD
-18.41 (-2.10%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $848.00 -11.88 (-1.38%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Eli Lilly and Company [LLY]
Reports for Purchase
Showing records 221 - 240 ( 434 total )
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Healthcare - The Liver Meeting Abstracts Part 3: Newcomers to the NASH Space
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Healthcare: The Liver Meeting Abstracts Part 1: Diving Deep Into Large Pharma Abstracts
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
The Liver Meeting Abstracts Part 1: Diving Deep Into Large Pharma Abstracts
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY
Provider: Stock Traders Daily
Analyst: Research Department